NeuroMetrix encouraged by Phase II Quell data
NeuroMetrix reported trial data for its wireless transcutaneous electric nerve stimulation device for chemotherapy-induced peripheral neuropathy.

NeuroMetrix reported trial data for its wireless transcutaneous electric nerve stimulation device for chemotherapy-induced peripheral neuropathy.
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan
It’s a match! Connecting patients to clinical trials with AI